Coronavirus vaccine developer CureVac shares surge in U.S. debut - Reuters Canada

11:12am PDT - August 14th, 2020    stock-market - Reuters

Shares of German biotechnology firm CureVac BV nearly tripled in their Nasdaq debut on Friday, marking the first stock market debut of a company developing a potential vaccine to combat the novel coronavirus.